CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,456,000 | -30.1% | 360,299 | -24.1% | 0.20% | -25.4% |
| Q2 2016 | $2,084,000 | +26.4% | 474,799 | +8.9% | 0.27% | +22.4% |
| Q1 2016 | $1,649,000 | -37.1% | 436,120 | +160.8% | 0.22% | -34.2% |
| Q4 2015 | $2,622,000 | +97.0% | 167,215 | +32.4% | 0.33% | +88.1% |
| Q3 2015 | $1,331,000 | -46.4% | 126,309 | +28.3% | 0.18% | -40.0% |
| Q2 2015 | $2,484,000 | +14.2% | 98,477 | +26.2% | 0.30% | +15.7% |
| Q1 2015 | $2,176,000 | -29.3% | 78,060 | -53.7% | 0.26% | -31.8% |
| Q4 2014 | $3,076,000 | +53.3% | 168,560 | +8.9% | 0.37% | +49.6% |
| Q3 2014 | $2,006,000 | -10.0% | 154,759 | +13.2% | 0.25% | -7.4% |
| Q2 2014 | $2,230,000 | +11.1% | 136,659 | +20.2% | 0.27% | +8.4% |
| Q1 2014 | $2,008,000 | -28.6% | 113,659 | -2.2% | 0.25% | -29.3% |
| Q4 2013 | $2,812,000 | -11.2% | 116,159 | +30.0% | 0.35% | -17.2% |
| Q3 2013 | $3,166,000 | +55.2% | 89,359 | -31.6% | 0.42% | +44.6% |
| Q2 2013 | $2,040,000 | – | 130,659 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |